Abella, Michael B.

HRN: 23-74-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/05/2026
06/12/2026
PO
4.5ml
Q8hrs
Amoebiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: